tradingkey.logo

GE Healthcare Technologies Inc

GEHC
84.450USD
+0.490+0.58%
收盤 12/15, 16:00美東報價延遲15分鐘
38.47B總市值
17.40本益比TTM

GE Healthcare Technologies Inc

84.450
+0.490+0.58%

關於 GE Healthcare Technologies Inc 公司

GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.

GE Healthcare Technologies Inc簡介

公司代碼GEHC
公司名稱GE Healthcare Technologies Inc
上市日期Dec 15, 2022
CEOBankes (Jeannette)
員工數量53000
證券類型Ordinary Share
年結日Dec 15
公司地址500 West Monroe Street
城市CHICAGO
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編60661
電話18337351139
網址https://www.gehealthcare.com
公司代碼GEHC
上市日期Dec 15, 2022
CEOBankes (Jeannette)

GE Healthcare Technologies Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Peter J. Arduini
Mr. Peter J. Arduini
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
271.81K
-4.01%
Mr. Roland Rott
Mr. Roland Rott
President and CEO - Imaging
President and CEO - Imaging
64.93K
-1.69%
Mr. Kenneth Robert (Ken) Stacherski
Mr. Kenneth Robert (Ken) Stacherski
Chief Global Supply Chain and Service Officer
Chief Global Supply Chain and Service Officer
41.00K
-2.13%
Ms. Jeannette Bankes
Ms. Jeannette Bankes
Chief Executive Officer - Patient Care Solutions
Chief Executive Officer - Patient Care Solutions
37.03K
--
Mr. William J. Stromberg
Mr. William J. Stromberg
Independent Director
Independent Director
14.33K
+55.74%
Ms. Anne T. Madden
Ms. Anne T. Madden
Independent Director
Independent Director
13.61K
+55.32%
Dr. Rodney F. Hochman
Dr. Rodney F. Hochman
Independent Director
Independent Director
13.61K
+55.32%
Dr. Risa J. Lavizzo-Mourey, M.D.
Dr. Risa J. Lavizzo-Mourey, M.D.
Lead Independent Director
Lead Independent Director
10.16K
+43.77%
Dr. Tomislav Mihaljevic, M.D.
Dr. Tomislav Mihaljevic, M.D.
Independent Director
Independent Director
9.12K
+51.33%
Mr. Kevin Michael O'Neill
Mr. Kevin Michael O'Neill
Chief Executive Officer - Pharmaceutical Diagnostics
Chief Executive Officer - Pharmaceutical Diagnostics
165.00
-86.19%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Peter J. Arduini
Mr. Peter J. Arduini
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
271.81K
-4.01%
Mr. Roland Rott
Mr. Roland Rott
President and CEO - Imaging
President and CEO - Imaging
64.93K
-1.69%
Mr. Kenneth Robert (Ken) Stacherski
Mr. Kenneth Robert (Ken) Stacherski
Chief Global Supply Chain and Service Officer
Chief Global Supply Chain and Service Officer
41.00K
-2.13%
Ms. Jeannette Bankes
Ms. Jeannette Bankes
Chief Executive Officer - Patient Care Solutions
Chief Executive Officer - Patient Care Solutions
37.03K
--
Mr. William J. Stromberg
Mr. William J. Stromberg
Independent Director
Independent Director
14.33K
+55.74%
Ms. Anne T. Madden
Ms. Anne T. Madden
Independent Director
Independent Director
13.61K
+55.32%

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q1
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Total Imaging
2.20B
44.02%
Total Ultrasound
1.29B
25.74%
Total PCS
778.00M
15.54%
Total PDx
729.00M
14.56%
Other
6.00M
0.12%
由於公司未披露,未能獲取相關數據
業務
地區
業務USD
名稱
營收
佔比
Total Imaging
2.20B
44.02%
Total Ultrasound
1.29B
25.74%
Total PCS
778.00M
15.54%
Total PDx
729.00M
14.56%
Other
6.00M
0.12%

股東統計

更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
11.37%
Dodge & Cox
6.04%
Capital Research Global Investors
5.48%
BlackRock Institutional Trust Company, N.A.
5.41%
State Street Investment Management (US)
4.31%
其他
67.38%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
11.37%
Dodge & Cox
6.04%
Capital Research Global Investors
5.48%
BlackRock Institutional Trust Company, N.A.
5.41%
State Street Investment Management (US)
4.31%
其他
67.38%
股東類型
持股股東
佔比
Investment Advisor
47.07%
Investment Advisor/Hedge Fund
28.88%
Hedge Fund
3.52%
Research Firm
3.02%
Pension Fund
2.71%
Sovereign Wealth Fund
1.76%
Bank and Trust
1.29%
Insurance Company
0.80%
Individual Investor
0.28%
其他
10.65%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
2310
400.60M
85.71%
--
2025Q3
2366
400.81M
86.07%
+553.52K
2025Q2
2431
400.55M
88.05%
+24.13M
2025Q1
2426
405.65M
95.66%
-32.34M
2024Q4
2331
419.80M
91.27%
+20.88M
2024Q3
2167
398.38M
86.23%
+22.39M
2024Q2
2063
375.84M
84.85%
+4.36M
2024Q1
1976
370.75M
77.53%
+16.94M
2023Q4
1833
338.14M
75.18%
+5.23M
2023Q3
1683
332.60M
72.95%
+3.23M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
51.90M
11.37%
+696.51K
+1.36%
Jun 30, 2025
Dodge & Cox
23.57M
5.16%
+6.98M
+42.10%
Jun 30, 2025
Capital Research Global Investors
19.97M
4.38%
-1.99M
-9.05%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
24.63M
5.39%
-631.11K
-2.50%
Jun 30, 2025
State Street Investment Management (US)
19.66M
4.31%
+372.75K
+1.93%
Jun 30, 2025
Geode Capital Management, L.L.C.
11.94M
2.62%
+231.30K
+1.97%
Jun 30, 2025
Harris Associates L.P.
9.67M
2.12%
+4.04M
+71.68%
Jun 30, 2025
Invesco Capital Management (QQQ Trust)
9.37M
2.05%
-33.12K
-0.35%
Aug 31, 2025
Hotchkis and Wiley Capital Management, LLC
7.20M
1.58%
+1.45M
+25.17%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
6.32M
1.38%
+71.17K
+1.14%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Invesco S&P Spin-Off ETF
7.25%
Global X HealthTech ETF
4.14%
iShares U.S. Medical Devices ETF
4.07%
Absolute Select Value ETF
2.89%
VanEck Morningstar Wide Moat ETF
2.36%
Knowledge Leaders Developed World ETF
2.22%
Invesco Zacks Mid-Cap ETF
1.91%
Simplify Health Care ETF
1.77%
State Street SPDR S&P Health Care Equipment ETF
1.76%
First Trust NASDAQ-100 Ex-Technology Sector Index Fund
1.75%
查看更多
Invesco S&P Spin-Off ETF
佔比7.25%
Global X HealthTech ETF
佔比4.14%
iShares U.S. Medical Devices ETF
佔比4.07%
Absolute Select Value ETF
佔比2.89%
VanEck Morningstar Wide Moat ETF
佔比2.36%
Knowledge Leaders Developed World ETF
佔比2.22%
Invesco Zacks Mid-Cap ETF
佔比1.91%
Simplify Health Care ETF
佔比1.77%
State Street SPDR S&P Health Care Equipment ETF
佔比1.76%
First Trust NASDAQ-100 Ex-Technology Sector Index Fund
佔比1.75%

分紅派息

近5年累計派現 96.00M 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Sep 24, 2025
GEHC.NB Interim Cash Dividend of gross USD 0.035 paid on Nov 14, 2025 going ex on Oct 24, 2025
Oct 24, 2025
Nov 14, 2025
Oct 24, 2025
Jul 01, 2025
GEHC.NB Interim Cash Dividend of gross USD 0.035 paid on Aug 15, 2025 going ex on Jul 25, 2025
Jul 25, 2025
Aug 15, 2025
Jul 25, 2025
Mar 27, 2025
GEHC.NB Interim Cash Dividend of gross USD 0.035 paid on May 15, 2025 going ex on Apr 25, 2025
Apr 25, 2025
May 15, 2025
Apr 25, 2025
Nov 21, 2024
GEHC.NB Final Cash Dividend of gross USD 0.035 paid on Feb 14, 2025 going ex on Jan 14, 2025
Jan 14, 2025
Feb 14, 2025
Jan 14, 2025
Sep 18, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Nov 15, 2024 going ex on Oct 18, 2024
Oct 18, 2024
Nov 15, 2024
Oct 18, 2024
Jun 26, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 15, 2024 going ex on Jul 19, 2024
Jul 19, 2024
Aug 15, 2024
Jul 19, 2024
Mar 22, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on May 15, 2024 going ex on Apr 18, 2024
Apr 19, 2024
May 15, 2024
Apr 18, 2024
Dec 08, 2023
GEHC.NB Final Cash Dividend of gross USD 0.03 paid on Feb 15, 2024 going ex on Jan 12, 2024
Jan 16, 2024
Feb 15, 2024
Jan 12, 2024
Sep 22, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Nov 15, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 15, 2023
Oct 19, 2023
Jun 23, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 15, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Aug 15, 2023
Jul 20, 2023
查看更多

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

GE Healthcare Technologies Inc的前五大股東是誰?

GE Healthcare Technologies Inc的前五大股東如下:
The Vanguard Group, Inc.
持有股份:51.90M
佔總股份比例:11.37%。
Dodge & Cox
持有股份:23.57M
佔總股份比例:5.16%。
Capital Research Global Investors
持有股份:19.97M
佔總股份比例:4.38%。
BlackRock Institutional Trust Company, N.A.
持有股份:24.63M
佔總股份比例:5.39%。
State Street Investment Management (US)
持有股份:19.66M
佔總股份比例:4.31%。

GE Healthcare Technologies Inc的前三大股東類型是什麼?

GE Healthcare Technologies Inc 的前三大股東類型分別是:
The Vanguard Group, Inc.
Dodge & Cox
Capital Research Global Investors

有多少機構持有GE Healthcare Technologies Inc(GEHC)的股份?

截至2025Q4,共有2310家機構持有GE Healthcare Technologies Inc的股份,合計持有的股份價值約為400.60M,占公司總股份的85.71% 。與2025Q3相比,機構持股有所增加,增幅為-0.36%。

哪個業務部門對GE Healthcare Technologies Inc的收入貢獻最大?

在FY2025Q2,Total Imaging業務部門對GE Healthcare Technologies Inc的收入貢獻最大,創收2.20B,占總收入的44.02% 。
KeyAI